Learn More
A prerequisite for the prediction of the magnitude of P-glycoprotein (P-gp)-mediated drug-drug interactions between digoxin and P-gp inhibitors (e.g. verapamil and its metabolite norverapamil) or(More)
Digoxin is the recommended substrate for assessment of P-glycoprotein (P-gp)-mediated drug-drug interactions (DDIs) in vivo. The overall aim of our study was to investigate the inhibitory potential(More)
EVA is a new molecular descriptor that provides a concise summary of the fundamental frequency components of a molecule's infrared range vibrational spectrum in a vector format. Target structures(More)